David Spaight Joins MDS as President of Pharma Services
27 Aprile 2006 - 2:00PM
PR Newswire (US)
Seasoned life sciences executive to lead MDS's largest business
TORONTO, April 27 /PRNewswire-FirstCall/ -- MDS Inc. (NYSE: MDZ;
TSX: MDS), a leading provider of enabling products and services to
the global life sciences markets, announced today that David
Spaight has joined as President of MDS Pharma Services, effective
immediately. Mr. Spaight will report directly to Stephen P.
DeFalco, President and Chief Executive Officer of MDS Inc. Mr.
Spaight brings over 20 years of experience in the life sciences
industry. Most recently, he served as Senior Vice - President,
Global Sales and Marketing at Fisher Scientific Products, where he
was responsible for the integration of the sales, marketing, and
research and development teams in North America, Europe and Asia.
Prior to joining Fisher, Mr. Spaight had an extensive career at
PerkinElmer, Inc. where he rose up through sales, marketing, and
general management positions to the role of Vice - President,
Global Sales and Marketing. In this role he led a global workforce
of over 1400 people, in 40 countries and was responsible for $1.1 B
in revenues. Mr. Spaight has extensive experience in business
development and operational improvement. Mr. Spaight has a Bachelor
of Science in Chemistry and a Masters in Business Administration,
both from the University of Michigan. "David brings deep expertise
in the global life sciences industry and an impressive track record
of success," said Stephen P. DeFalco, President and CEO, MDS Inc.
"His appointment comes at a crucial stage for MDS Pharma Services,
as we continue to reposition the business and improve operating
results." "I am excited to join MDS Pharma Services at this time of
tremendous opportunity. Together with the management team, we will
build on MDS Pharma Service's market-leading positions and drive to
top quartile performance," said Mr. Spaight. Gilbert Godin, former
President of MDS Pharma Services, is leaving the Company to pursue
a leadership opportunity in the specialty pharmaceutical industry.
About MDS Pharma Services MDS Pharma Services offers a full
spectrum of resources to meet the drug discovery and development
needs of the pharmaceutical and biotechnology industries. With
numerous facilities strategically located around the world, the
company applies advanced scientific and technological expertise to
each stage of the drug discovery and development process - Early
Stage: lead optimization, pre-IND research, pharmaceutical and
biopharmaceutical development, early clinical research
(bioequivalence, phases I-IIa) and bioanalysis; and Late Stage:
global clinical development (phases IIb-IV) and central lab. For
more information, visit MDS Pharma Services' Web site at
http://www.mdsps.com/. About MDS Inc. MDS Pharma Services is an
integral part of MDS Inc. (TSX: MDS; NYSE: MDZ). MDS Inc. has more
than 8,800 highly skilled people in 27 countries. We provide a
diverse range of superior products and services to increase our
customers' speed, precision and productivity in the drug
development and disease diagnosis processes. We are a global,
values-driven life sciences company, recognized for our reliability
and collaborative relationships as we help create better outcomes
in the treatment of disease. Find out more at
http://www.mdsinc.com/ or by calling 1-800-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers, Vice -
President, Investor Relations and External Communications, (416)
213-4721,
Copyright